Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose 90Y-hMN-14 with PBSC Rescue in Colorectal and Pancreatic Cancer
NCT00004087Phase 2Completed
- Sponsor
- Garden State Cancer Center
- Start
- Mar 1997
- Primary completion
- May 2001
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of yttrium-90 labetuzumab in colorectal cancer (CRC), pancreatic cancer (PC), sponsored by Garden State Cancer Center. Started Mar 1997; status: completed.
02
Drugs
yttrium-90 labetuzumab
03
Conditions
colorectal cancer (CRC)pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00004087.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00004087.